دورية أكاديمية

ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer

التفاصيل البيبلوغرافية
العنوان: ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
المؤلفون: Koca, Emre, Niravath, Polly Ann, Ensor, Joe, Patel, Tejal Amar, Li, Xiaoxian, Hemati, Pej, Wong, Helen, Qian, Wei, Boone, Toniva, Zhao, Jing, Ramshesh, Priya V., Cohen, Adam Louis, Murthy, Asha, Nair, Sindhu, Darcourt, Jorge German, Belcheva, Anna, Kaklamani, Virginia G., Chang, Jenny Chee Ning
المساهمون: Takeda Pharmaceuticals U.S.A.
المصدر: Breast Cancer Research and Treatment ; volume 188, issue 2, page 433-439 ; ISSN 0167-6806 1573-7217
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2021
مصطلحات موضوعية: Cancer Research, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s10549-021-06214-7
DOI: 10.1007/s10549-021-06214-7.pdf
DOI: 10.1007/s10549-021-06214-7/fulltext.html
الإتاحة: https://doi.org/10.1007/s10549-021-06214-7Test
حقوق: https://www.springer.com/tdmTest ; https://www.springer.com/tdmTest
رقم الانضمام: edsbas.D2063C1A
قاعدة البيانات: BASE